Abstract
Abstract Background Children's Hospital of Philadelphia (CHOP) clinicians observed an increase in invasive group A Streptococcus infections (iGAS) in November 2022. In December 2022, the Centers for Disease Control and Prevention published an investigation of increased iGAS. At CHOP iGAS remain increased, even after peak respiratory viral season. Our objective was to compare pre-pandemic and current case counts and to investigate if the increase in iGAS correlates with an increase in non-invasive GAS infections (nGAS). Methods Data for positive Streptococcus pyogenes results at CHOP from January 2018 to April 2023 was collected from the electronic medical record (n=466). Results were classified by source and specimen type as pharyngitis, superficial, and invasive, then further classified as non-invasive (pharyngitis and superficial) or invasive. For infection events with multiple results only one result was included, giving preference to the most aggressive classification (invasive >pharyngitis >superficial). Fisher's exact test was used to assess association between the increase in nGAS and iGAS prior to and after the start of the COVID-19 pandemic (2018-2019 vs. 2021-2023). Fisher's exact test, with Monte Carlo simulation, was used to assess association between the increase in nGAS and iGAS infections by year. Results There was a statistically significant association in the increase in pharyngitis, superficial, and invasive group A Streptococcus infections (GAS) (p-value < 0.0001) and in nGAS and iGAS (p-value = 0.0001), when comparing pre- and post-2020. We found statistically significant associations in the increase of pharyngitis, superficial, and invasive GAS cases (p-value = 0.0005) and of nGAS and iGAS cases (p-value = 0.0005). Conclusion Our data shows a significant increase in cases from pre-pandemic years for nGAS and iGAS infections. iGAS is correlated with nGAS, even with further stratification of nGAS into pharyngitis and superficial. Notably, increases in nGAS were significantly more than the increase in iGAS, which has unexpectedly persisted beyond the typical winter viral infection peak. Continued monitoring or GAS, particularly iGAS, is justified. Disclosures All Authors: No reported disclosures
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.